BIR Leadership 2022 – Richards’ Review to reality

7th February 2022  18:00 - 20:30 (GMT+01:00) Europe/London

Virtual event – Monday 7 February 18:00-20:30 GMT
3 CPD Credits


Following on from the successful BIR Leadership event in 2021 on the Richards' Review (including hearing from Sir Mike Richards himself), this year the focus will be on the progress so far. We have a line-up of exciting talks and speakers for you, covering community diagnostic hubs, imaging networks and AI. A virtual evening event not to be missed.

This event is for all those interested and involved in leadership across the imaging community.

View event programme


Registration fees:

Non-members £100

World Partner Network members £65

BIR Plan 1 members £65

BIR Plan 2 members £55

BIR International members £55

BIR Trainee members £55

BIR Retired / Student members £45

Payment for all events must be made via a debit or credit card. Invoices and PO numbers cannot be used for registration payment. If you need your hospital, Trust, or organisation to pay for registration fees we advise them to fill out the event registration form and return to Please note VAT will be added for all virtual events to the registration fees listed. For any further inquiries please contact

If you are having issues registering for the event please create or login to your MyBIR account via this link and then register for the event after you have logged in. If you are still experiencing any issues please email

Further updates

Follow us on Twitter @BIR_News or sign up for our email alerts here to get further updates on our educational programmes


Become a member of the BIR to gain access to hundreds of other webinars and online learning tools for free today!





Advanced Accelerator Applications

Advanced Accelerator Applications, S.A. (AAA), a Novartis company, is an innovative medicines company developing targeted radioligand therapies and precision imaging radioligands for oncology. We are committed to transforming patients’ lives by leading innovation in nuclear medicine. AAA currently has over 1,000 employees working across 31 sites in 12 countries (Canada, France, Germany, Israel, Italy, the Netherlands, Poland, Portugal, Spain, Switzerland, the UK and the US). The company also has global manufacturing capabilities with 19 facilities in eight countries, and six research & development sites. For more information, please visit:

Bayer Healthcare

Bayer’s Radiology business is well placed to be the partner of choice in helping NHS trusts to address the many challenges faced today including the increasing need for governance to demonstrate best practice and improving patient care within increasing financial constraints. With market-leading contrast media and power injector systems, Bayer is able to offer innovative patient care and with the addition of its informatics platform, it can support radiology departments in driving protocol standardisation and easily accessible audit data that enable departments to meet further challenges faced around contrast and radiation dose management. 0118 2063999

GE Healthcare Ltd

GE Healthcare is a leading provider of medical imaging, monitoring, and life science technologies. GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services to help providers, researchers and life sciences companies in their mission to improve outcomes for patients around the world.

InHealth Ltd

InHealth is the UK’s largest specialist provider of diagnostic and healthcare solutions. Our vision is to make healthcare better, by working with hospitals and commissioners across the NHS and Independent sector. With more than 25 years experience, this approach is helping to meet some of health’s most pressing challenges – reducing waiting times, speeding up diagnoses, saving money and improving the overall patient experience. InHealth provides tests, scans and examinations for more than 3 million patients a year, across the UK and 98% of our patients are likely or more than likely to recommend us to friends and family. We work collaboratively with NHS and private sector referrers to improve access, affordability and timely diagnosis and treatment for patients. We have over 2,500 members of staff, with c.1,500 clinical specialists and patient management teams. We have over £150 million worth of assets, including a wide range of complex diagnostic imaging equipment. We invest all cash surplus in new technologies and equipment

Philips Healthcare

Enabling better health and better care at lower cost Philips is a leading health technology company focused on improving people`s lives across the health continuum - from healthy living and prevention, to diagnosis, treatment and home care. Applying advanced technologies and deep clinical and consumer insights, Philips delivers integrated solutions that improve people`s health and enable better outcomes. Partnering with its customers, Philips seeks to transform how healthcare is delivered and experienced. The company is a leader in diagnostic imaging, image-guided therapy, patient monitoring and health informatics, as well as in consumer health and home care.

Siemens Healthineers

Siemens Healthineers pioneers breakthroughs in healthcare. For everyone. Everywhere. As a leading medical technology company Siemens Healthineers is continuously developing its product and service portfolio, with AI-supported applications and digital offerings that play an increasingly important role in the next generation of medical technology. These new applications will enhance the company’s foundation in in-vitro diagnostics, image-guided therapy, in-vivo diagnostics, and innovative cancer care. Siemens Healthineers also provides a range of services and solutions to enhance healthcare providers’ ability to provide high-quality, efficient care. Further information is available at